Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease. Jordi Rimola, Joana Torres,...

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice. Masataka Masuda, Norimasa...

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom? Jia-Feng Wu, Published...

Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel...

Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study. Su...

CD147 Targeting by AC-73 Induces Autophagy and Reduces Intestinal Fibrosis Associated with TNBS Chronic Colitis. Alessia Butera, Maria...

Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases....

Assessing the inflammatory severity of the terminal ileum in Crohn disease using radiomics based on MRI. Honglei Ding, Jiaying Li, Kefang...

A Swaminathan, G M Borichevsky, T S Edwards, E Hirschfeld, T C Mules, C M Frampton, A S Day, M B Hampton, A J Kettle, R B Gearry...

Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and...

Tofacitinib Response in Ulcerative Colitis (TOUR): Early Response After Initiation of Tofacitinib Therapy in a Real-world Setting. Millie...

M Ghiboub, S Penny, C M Verburgt, R Sigall Boneh, E Wine, A Cohen, K A Dunn, D M Pinto, M A Benninga, W J de Jonge, A Levine, J E Van...